INTIMATION FOR BODHIKA SEMINAR 15/02/2023
DEPARTMENT OF PRASUTITANTRA AND STREEROGA
NAME OF FIRST PRESENTEE:Dr. Gopika Raj
TIME: 2:00-4:00 PM
VENUE: COLLEGE AUDITORIUM
Uterine
fibroids also known as Leiomyomas are benign smooth muscle tumours of the
uterus. It is predominantly an estrogen dependent tumour. It has been estimated
that about 20% -80% of women develop fibroid at the age of fifty. Prevalence is
highest between 35 and 45 years. Ayurveda has been able to considerably
contribute to the management of fibroid. Many formulations are being
effectively used in clinical practice and have been studied scientifically with
proven results. Chiruvilwadi Kashaya mentioned in Sahasrayogam Arshas
chikitsa and Kanchanara Guggulu mentioned in Sarngadhara
Samhitha Madhyamakhanda Vatakavidhi Adhyaya is selected for the
study. Uterine fibroids may be correlated to Garbhashayagatha Mamsagranthi
caused by Tridosha dushti with Vatha Kapha predominance along
with vitiation of Raktha, Mamsa and Medho dhatu. Hence the treatment
aims at Vatha kapha hara and Medho hara action. Analyzing the dosha
karma of the above formulation, easy availability and cost effectiveness of
the drug ensure this medicine as a right choice. Study design is pre and post
interventional with a sample size of 30. Females in the age group of 25-45
years who are diagnosed with Uterine Fibroids of size less than 8 cm will be
selected from the OPD of Government Ayurveda College, Thiruvananthapuram. Women
with malignancy, other chronic systemic illness, post-menopausal women, fibroid
with degenerative changes, sub mucous fibroids, pregnant and lactating women
and in those with Haemoglobin level less than 8g/dl will be excluded. Study tools
include lab investigation, Ultrasonogram and case proforma. Patients satisfying
the above criteria will be included in the study. Duration of the treatment
will be 90 days and Chiruvilwadi Kashaya will be dispensed in the form
of coarse powder in packets of 48 gm and Kanchanara Guggulu will be
given in pill form of 1.5g each. Medicines will be dispensed on monthly basis
and patients will be advised to take 48 ml of kashaya twice daily before
food along with Kanchanara Guggulu 1.5g twice a day and will be reviewed
after every 30 days during the study period. Outcome variables, change in size
of fibroid will be assessed using USG and associated symptoms like dysmenorrhea
and amount of bleeding will also be assessed. Results will be statistically analysed
using Wilcoxon’s signed rank test and Paired‘t’ test according to type of
distribution of variable. Results will be drawn, summarized and conclusions
will be made.






